ICD-10-CM 2027
ICD-10 code for Antiplatelet long-term drug therapy
Long term (current) use of antithrombotics/antiplatelets
From the official ICD-10-CM alphabetic index entry “Long-term (current) (prophylactic) drug therapy (use of) › antiplatelet”. Page updated September 29, 2026.
About coding Antiplatelet long-term drug therapy
The ICD-10-CM code for Antiplatelet long-term drug therapy is Z79.02 (Long term (current) use of antithrombotics/antiplatelets).
Within Z79.0 (long term (current) use of anticoagulants and antithrombotics/antiplatelets), Z79.02 is specifically for long term (current) use of antithrombotics/antiplatelets. Related codes cover anticoagulants (Z79.01).
It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.
In MS-DRG v44.0, it is part of the grouping logic for DRG 949 (Aftercare with CC/MCC, relative weight 1.123) and DRG 950 (Aftercare without CC/MCC, relative weight 0.7664), in MDC 23 (Factors Influencing Health Status and Other Contacts with Health Services), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
Common questions about Antiplatelet long-term drug therapy ICD-10 codes
What is the ICD-10 code for Antiplatelet long-term drug therapy?
- Z79.02 — Long term (current) use of antithrombotics/antiplatelets.
Is Z79.02 billable?
- Yes. Z79.02 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can Z79.02 be used as a principal diagnosis?
- No. It is not acceptable as the principal diagnosis for an inpatient stay; it may be reported as a secondary diagnosis.
Is Z79.02 a CC or MCC?
- No. Z79.02 is neither a CC nor an MCC under MS-DRG v44.0.